| [1] |
Benson AB, Venook AP, Al-Hawary MM, et al. NCCN guidelines insights: colon cancer, Version 2.2018[J]. Journal of the National Comprehensive Cancer Network: JNCCN, 2018, 16(4): 359-369.
|
| [2] |
Chen WQ, Li H, Sun KX, et al. Report of Cancer Incidence and Mortality in China, 2014[J]. Chinese Journal of Oncology, 2018, 40(1): 5-13.
|
| [3] |
Dienstmann R, Salazar R, Tabernero J. Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients[J]. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 2015, 33(16): 1787-1796.
|
| [4] |
Frampton M, Houlston RS. Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors[J]. Genetics in medicine: official journal of the American College of Medical Genetics, 2017, 19(3): 314-321.
|
| [5] |
Croci DO, Zacarías Fluck MF, Rico MJ, et al. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment[J]. Cancer immunology, immunotherapy: CII. 2007, 56(11): 1687-1700.
|
| [6] |
Broussard EK, Kim R, Wiley JC, et al. Identification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions[J]. Cancer prevention research (Philadelphia, Pa.), 2013, 6(7): 666-674.
|
| [7] |
O'Connell J, Bennett MW, Nally K, et al. Altered mechanisms of apoptosis in colon cancer: fas resistance and counterattack in the tumor-immune conflict[J]. Annals of the New York Academy of Sciences, 2000, 910:178-192; discussion 193-175.
|
| [8] |
Tauriello DVF, Palomo-Ponce S, Stork D, et al. Tgfβ drives immune evasion in genetically reconstituted colon cancer metastasis[J]. Nature, 2018, 554(7693): 538-543.
|
| [9] |
Abbas AR, Baldwin D, Ma Y, et al. Immune response in silico (iris): immune-specific genes identified from a compendium of microarray expression data[J]. Genes and immunity, 2005, 6(4): 319-331.
|
| [10] |
Weinstein JN, Collisson EA, Mills GB, et al. The cancer genome atlas pan-cancer analysis project[J]. Nature genetics, 2013, 45(10): 1113-1120.
|
| [11] |
Bhattacharya S, Dunn P, Thomas CG, et al. Immport, toward repurposing of open access immunological assay data for translational and clinical research[J]. Scientific data, 2018, 5: 180015.
|
| [12] |
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for Rna-Seq data with Deseq2[J]. Genome biology, 2014, 15(12): 550.
|
| [13] |
Yu G, Wang LG, Han Y, et al. Clusterprofiler: an r package for comparing biological themes among gene clusters[J]. Omics: a journal of integrative biology, 2012, 16(5): 284-287.
|
| [14] |
Gene Ontology Consortium. Gene Ontology Consortium: going forward[J]. Nucleic Acids Res, 2015, 43 (Database issue): D1049-1056.
|
| [15] |
Goel MK, Khanna P, Kishore J. Understanding Survival Analysis: Kaplan-Meier Estimate[J]. International journal of Ayurveda research. 2010; 1(4): 274-278.
|
| [16] |
Jiang X, Cooper GF, Neill DB. Generalized Amoc Curves for Evaluation and Improvement of Event Surveillance. AMIA Annual Symposium proceedings[J]. AMIA Symposium, 2009, 2009: 281-285.
|
| [17] |
Pagès F, Mlecnik B, Marliot F, et al. International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study[J].Lancet (London, England), 2018, 391(10135): 2128-2139.
|
| [18] |
Lee CH, Chen LC, Yu CC, et al. Prognostic value of Cd1b in localised prostate cancer[J]. Int J Environ Res Public Health, 2019, 16(23): 4723.
|
| [19] |
Liu S, Wang Y, Han Y, et al. Ereg-driven oncogenesis of head and neck squamous cell carcinoma exhibits higher sensitivity to erlotinib therapy[J]. Theranostics, 2020, 10(23): 10589-10605.
|
| [20] |
Lei Y, Takahama Y. Xcl1 and Xcr1 in the immune system[J]. Microbes and infection, 2012, 14(3): 262-267.
|